KANE BIOTECH INC (KNE.CA) Stock Overview
TSX-V:KNE - CA4838092084 - Common Stock
KNE.CA Key Statistics, Chart & Performance
The current stock price of KNE.CA is 0.0425 CAD. In the past month the price increased by 6.25%. In the past year, price decreased by -72.58%.
KNE.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 425.87M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 343.98M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 266.82M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 204.61M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 103.88M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 97.56M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 90.92M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 82.42M | ||
| NRX.CA | NUREXONE BIOLOGIC INC | N/A | 66.41M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 18.46 | 65.81M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 60.21M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 45.90M |
Related stock screener links
About KNE.CA
Company Profile
Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company is headquartered in Winnipeg, Manitoba. The company went IPO on 2003-05-07. The Company’s segments include Animal health, and Human health. The company has a portfolio of technologies, intellectual property (patents, patents pending and trademarks) and products developed by the Company’s own biofilm research and acquired from research institutions. DispersinB, coactiv+TM, coactiv+, DermaKBTM, DermaKB BiofilmTM and revyveTM are trademarks of Kane Biotech. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. The firm's other biofilm disruption technology is DispersinB. DispersinB is a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG). DispersinB cleaves PNAG, inhibiting bacterial adhesion and disperses the biofilm.
Company Info
KANE BIOTECH INC
290-100 Innovation Drive
Winnipeg MANITOBA R3T 2N2 CA
CEO: Marc Edwards
Employees: 0
Phone: 12044531301
KANE BIOTECH INC / KNE.CA FAQ
What is the stock price of KANE BIOTECH INC today?
The current stock price of KNE.CA is 0.0425 CAD. The price increased by 6.25% in the last trading session.
What is the ticker symbol for KANE BIOTECH INC stock?
The exchange symbol of KANE BIOTECH INC is KNE and it is listed on the TSX Venture Exchange exchange.
On which exchange is KNE.CA stock listed?
KNE.CA stock is listed on the TSX Venture Exchange exchange.
What is KANE BIOTECH INC worth?
KANE BIOTECH INC (KNE.CA) has a market capitalization of 7.05M CAD. This makes KNE.CA a Nano Cap stock.
How many employees does KANE BIOTECH INC have?
KANE BIOTECH INC (KNE.CA) currently has 0 employees.
What are the support and resistance levels for KANE BIOTECH INC (KNE.CA) stock?
KANE BIOTECH INC (KNE.CA) has a support level at 0.04 and a resistance level at 0.08. Check the full technical report for a detailed analysis of KNE.CA support and resistance levels.
Should I buy KANE BIOTECH INC (KNE.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KNE.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KNE.CA, evaluating the profitability, health, valuation and growth aspects
- KANE BIOTECH INC (KNE.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KANE BIOTECH INC (KNE.CA) Sales and EPS estimates to see what analysts future expectations are.
- KANE BIOTECH INC (KNE.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KANE BIOTECH INC (KNE.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- KANE BIOTECH INC (KNE.CA) Stock Chart to make your own analysis
- KANE BIOTECH INC (KNE.CA) Latest news and press-releases to stay up to date.
Does KANE BIOTECH INC (KNE.CA) stock pay dividends?
KNE.CA does not pay a dividend.
When does KANE BIOTECH INC (KNE.CA) report earnings?
KANE BIOTECH INC (KNE.CA) will report earnings on 2025-11-26.
What is the Price/Earnings (PE) ratio of KANE BIOTECH INC (KNE.CA)?
The PE ratio for KANE BIOTECH INC (KNE.CA) is 0.85. This is based on the reported non-GAAP earnings per share of 0.05 and the current share price of 0.0425 CAD. Check the full fundamental report for a full analysis of the valuation metrics for KNE.CA.
KNE.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to KNE.CA. When comparing the yearly performance of all stocks, KNE.CA is a bad performer in the overall market: 97.48% of all stocks are doing better.
KNE.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KNE.CA. KNE.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
KNE.CA Financial Highlights
Over the last trailing twelve months KNE.CA reported a non-GAAP Earnings per Share(EPS) of 0.05. The EPS increased by 174.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 255.02% | ||
| ROA | 225.92% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |